Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.

M Deguillien1, S C Huang, M Morinière

  • 1Centre de Génétique Moléculaire et Cellulaire, CNRS UMR 5534, Université Lyon 1, Villeurbanne, France.

Blood
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines.

Blood cancer journal·2014
Same author

Pulmonary embolism by amniotic fluid; report of three cases with a new diagnostic procedure.

Surgery, gynecology & obstetrics·2010
Same author

Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.

Oncogene·2010
Same author

Comprehensive cancer centres and the war on cancer.

Nature reviews. Cancer·2002
Same author

Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas.

European journal of clinical investigation·2001
Same author

A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation.

BMC genetics·2001
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Exon 16 inclusion in protein 4.1R messenger RNA (mRNA) is vital for red blood cell membrane formation. Regulatory elements within the gene control this splicing event during erythroid development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Protein 4.1R is crucial for red blood cell membrane stability.
  • Exon 16 inclusion in protein 4.1R mRNA is essential for erythroid development.
  • Splicing regulation of exon 16 is key to proper protein 4.1R function.

Purpose of the Study:

  • To investigate the cis-acting regulatory sequences controlling exon 16 splicing in protein 4.1R.
  • To establish a model system for studying erythroid-specific splicing.
  • To understand the molecular mechanisms behind exon 16 inclusion during erythroid differentiation.

Main Methods:

  • Transfection of a minigene into murine erythroleukemia cells.
  • Analysis of splicing patterns before and after induction of differentiation.

Related Experiment Videos

  • Systematic deletion and mutation analysis of cis-acting elements in introns and exon.
  • Main Results:

    • The upstream intron contains distal and proximal enhancer elements for exon recognition.
    • The exon itself harbors a constitutive splicing silencer and a weak 5' splice site.
    • The downstream intron possesses enhancer elements, including UGCAUG motifs, active during differentiation.

    Conclusions:

    • A balance of positive and negative regulatory elements governs exon 16 splicing.
    • Activation of enhancer elements during late erythroid differentiation promotes exon 16 inclusion.
    • These findings elucidate the regulatory network controlling protein 4.1R mRNA processing in red blood cells.